Chemical structure of molecule Maralixibat Mirum Pharmaceuticals IBAT bile acid transporter inhibitor

oral gut-restricted bile acid transporter inh.

approved for cholestatic pruritis in Sep. 2021

repurposed (first patented in 1994)

The Lancet

Mirum / Pfizer / Pharmacia / Searle

The Mirum Pharmaceuticals IBAT bile acid transporter inhibitor, maralixibat, has a long history, having been first patented by scientists at Searle in 1994 and published by the time Searle became part of…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.